A Single-Center, Single-Arm, Phase 1b Study to Evaluate the Effects of ADO-5030 on a Bronchoconstriction Challenge
Latest Information Update: 18 Dec 2025
At a glance
- Drugs ADO 5030 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Adovate
Most Recent Events
- 18 Dec 2025 New trial record